The authors suggested that the active release of HMGB1 mRNA in this remodeling phase is from the infiltrating inflammatory cells and that it might contribute to the prolonged post-MI inflammatory response leading to adverse remodeling [32]. This evidence concerns the gene HMGB1 and myocardial infarction.